Sezer O - Search Results

1

Colitis associated with docetaxel-based chemotherapy.

Sezer O, Eucker J, Possinger K. Sezer O, et al. Lancet. 2000 May 20;355(9217):1823-4. doi: 10.1016/S0140-6736(05)73080-4. Lancet. 2000. PMID: 10832856 No abstract available.

2

Diagnosis and treatment of AL amyloidosis.

Sezer O, Eucker J, Jakob C, Possinger K. Sezer O, et al. Clin Nephrol. 2000 Jun;53(6):417-23. Clin Nephrol. 2000. PMID: 10879660 Review.

3

Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia.

Sezer O, Schmid P, Hallek M, Schweigert M, Beinert T, Langelotz C, Mergenthaler HG, Possinger K. Sezer O, et al. Ann Hematol. 1999 Oct;78(10):475-7. doi: 10.1007/s002770050602. Ann Hematol. 1999. PMID: 10550560 Review.

4

Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy.

Sezer O, Niemöller K, Kaufmann O, Eucker J, Jakob C, Zavrski I, Possinger K. Sezer O, et al. Eur J Haematol. 2001 Apr;66(4):238-44. doi: 10.1034/j.1600-0609.2001.066004238.x. Eur J Haematol. 2001. PMID: 11380603

5

Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation.

Sezer O, Eucker J, Bauhuis C, Schweigert M, Lüftner D, Kalus U, Späth-Schwalbe E, Arnold R, Possinger K. Sezer O, et al. Ann Hematol. 2000 Nov;79(11):627-30. doi: 10.1007/s002770000218. Ann Hematol. 2000. PMID: 11131922

6

Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support.

Sezer O, Schmid P, Shweigert M, Heider U, Eucker J, Harder H, Sinha P, Radtke H, Possinger K. Sezer O, et al. Bone Marrow Transplant. 1999 May;23(9):967-9. doi: 10.1038/sj.bmt.1701765. Bone Marrow Transplant. 1999. PMID: 10338056

7

New therapeutic approaches in primary systemic AL amyloidosis.

Sezer O, Eucker J, Schmid P, Possinger K. Sezer O, et al. Ann Hematol. 2000 Jan;79(1):1-6. doi: 10.1007/s002770050001. Ann Hematol. 2000. PMID: 10663614 Review.

8

Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.

Akrivakis K, Schmid P, Flath B, Schweigert M, Sezer O, Mergenthaler HG, Possinger K. Akrivakis K, et al. Among authors: sezer o. Anticancer Drugs. 1999 Jul;10(6):525-31. doi: 10.1097/00001813-199907000-00003. Anticancer Drugs. 1999. PMID: 10885899 Clinical Trial.

9

Novel approaches to the treatment of primary amyloidosis.

Sezer O, Niemöller K, Jakob C, Langelotz C, Eucker J, Possinger K. Sezer O, et al. Expert Opin Investig Drugs. 2000 Oct;9(10):2343-50. doi: 10.1517/13543784.9.10.2343. Expert Opin Investig Drugs. 2000. PMID: 11060811 Review.

10

Achievement of complete remission in refractory Hodgkin's disease with prolonged infusion of gemcitabine.

Sezer O, Eucker J, Jakob C, Kaufmann O, Schmid P, Possinger K. Sezer O, et al. Invest New Drugs. 2001;19(1):101-4. doi: 10.1023/a:1006478702342. Invest New Drugs. 2001. PMID: 11291828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters